MARKSANS PHARMA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 263.25 INR | +1.89% |
|
+8.50% | +63.30% |
| Aug. 21 | Marksans Pharma Arm Gets UK Regulator's Marketing Nod for Fluoxetine Capsules | MT |
| Aug. 20 | Marksans Pharma Gets US FDA's EIR for Goa, India Unit | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.39B | - | - | ||||
| 818B | ||||||
| 582B | ||||||
| 401B | ||||||
| 347B | ||||||
| 293B |
